We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals high healthcare costs related to CRS and ICANS in adults with B-ALL, suggesting financial impact of CAR T-cell therapy.
No takes yet. Share an insight, caveat, or question.
Roeland et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: